Eiger Biopharma Raises $7.1 Million
peHUB -- Eiger Biopharmaceuticals Inc., a Palo Alto, Calif.-based drug startup, has raised $7.1 million in Series A funding, according to a regulatory filing. Backers include InterWest Partners and Vivo Ventures. The company does not have a public website.